Cargando…

NFE2L3 drives hepatocellular carcinoma cell proliferation by regulating the proteasome‐dependent degradation of ISGylated p53

Nuclear factor erythroid 2‐like 3 (NFE2L3) is a member of the cap ‘n’ collar basic‐region leucine zipper (CNC‐bZIP) transcription factor family that plays a vital role in modulating oxidation–reduction steady‐state and proteolysis. Accumulating evidence suggests that NFE2L3 participates in cancer de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Yonggang, Yang, Jing, Ding, Zhiran, Zheng, Menghua, Qiu, Lu, Tang, Aifa, Huang, Dandan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475773/ https://www.ncbi.nlm.nih.gov/pubmed/37350063 http://dx.doi.org/10.1111/cas.15887

Ejemplares similares

NFE2L3 promotes malignant behavior and EMT of human hepatocellular carcinoma (HepG2) cells via Wnt/β‑catenin pathway
por: Ren, Yonggang, et al.
Publicado: (2020)

Oncogene-mediated regulation of p53 ISGylation and functions
por: Huang, Yi-Fu, et al.
Publicado: (2014)

ISGylation is induced in neurons by demyelination driving ISG15-dependent microglial activation
por: Clarkson, Benjamin D. S., et al.
Publicado: (2022)

ISGylation orchestrates the degradation flux of cellular cargo toward lysosome
por: Huang, Min-Yi, et al.
Publicado: (2021)

NFE2L1-mediated proteasome function protects from ferroptosis
por: Kotschi, Stefan, et al.
Publicado: (2022)

Upregulation of Enzymes involved in ISGylation and Ubiquitination in patients with hepatocellular carcinoma
por: Tong, Hoang Van, et al.
Publicado: (2020)

ISGylation controls exosome secretion by promoting lysosomal degradation of MVB proteins
por: Villarroya-Beltri, Carolina, et al.
Publicado: (2016)

ISGylation drives basal breast tumour progression by promoting EGFR recycling and Akt signalling
por: Bolado-Carrancio, Alfonso, et al.
Publicado: (2021)

ISG15 and ISGylation in Human Diseases
por: Mirzalieva, Oygul, et al.
Publicado: (2022)

Proteomics Mapping of the ISGylation Landscape in Innate Immunity
por: Thery, Fabien, et al.
Publicado: (2021)

The Functional Roles of ISG15/ISGylation in Cancer
por: Yuan, Yin, et al.
Publicado: (2023)

TRAF7 contributes to tumor progression by promoting ubiquitin-proteasome mediated degradation of P53 in hepatocellular carcinoma
por: Zhang, Qi, et al.
Publicado: (2021)

Targeting the Ubiquitylation and ISGylation Machinery for the Treatment of COVID-19
por: Vere, George, et al.
Publicado: (2022)

90K Glycoprotein Promotes Degradation of Mutant β-Catenin Lacking the ISGylation or Phosphorylation Sites in the N-terminus()()
por: Park, So-Yeon, et al.
Publicado: (2016)

Overexpression of Nfe2l1 increases proteasome activity and delays vision loss in a preclinical model of human blindness
por: Wang, Yixiao, et al.
Publicado: (2023)

Consecutive Inhibition of ISG15 Expression and ISGylation by Cytomegalovirus Regulators
por: Kim, Ye Ji, et al.
Publicado: (2016)

Protein ISGylation: a posttranslational modification with implications for malignant neoplasms
por: Tecalco-Cruz, Angeles C., et al.
Publicado: (2023)

Dysfunction of the energy sensor NFE2L1 triggers uncontrollable AMPK signaling and glucose metabolism reprogramming
por: Qiu, Lu, et al.
Publicado: (2022)

ISGylation of EMD promotes its interaction with PDHA to inhibit aerobic oxidation in lung adenocarcinoma
por: Zhang, Congcong, et al.
Publicado: (2022)

HyperISGylation of Old World Monkey ISG15 in Human Cells
por: Pattyn, Els, et al.
Publicado: (2008)

Inflammatory osteolysis is regulated by site-specific ISGylation of the scaffold protein NEMO
por: Adapala, Naga Suresh, et al.
Publicado: (2020)

ISGylation in Innate Antiviral Immunity and Pathogen Defense Responses: A Review
por: Zhang, Mengdi, et al.
Publicado: (2021)

HERC5 and the ISGylation Pathway: Critical Modulators of the Antiviral Immune Response
por: Mathieu, Nicholas A., et al.
Publicado: (2021)

ISG15 suppresses ovulation and female fertility by ISGylating ADAMTS1
por: Chen, Yaru, et al.
Publicado: (2023)

Proteasome in action: substrate degradation by the 26S proteasome
por: Sahu, Indrajit, et al.
Publicado: (2021)

Patient-Derived Mutant Forms of NFE2L2/NRF2 Drive Aggressive Murine Hepatoblastomas
por: Wang, Huabo, et al.
Publicado: (2021)

Crucial Role of TSC-22 in Preventing the Proteasomal Degradation of p53 in Cervical Cancer
por: Yoon, Cheol-Hee, et al.
Publicado: (2012)

The proteasome and the degradation of oxidized proteins: Part II – protein oxidation and proteasomal degradation
por: Jung, Tobias, et al.
Publicado: (2013)

Proteasome-dependent degradation of intracellular carbamylated proteins
por: Desmons, Aurore, et al.
Publicado: (2019)

β-catenin ISGylation promotes lipid deposition and apoptosis in ethanol-stimulated liver injury models
por: Ding, Qi, et al.
Publicado: (2022)

Modulation of the Host Interferon Response and ISGylation Pathway by B. pertussis Filamentous Hemagglutinin
por: Dieterich, Christine, et al.
Publicado: (2011)

Decoupling deISGylating and deubiquitinating activities of the MERS virus papain-like protease
por: Clasman, Jozlyn R., et al.
Publicado: (2020)

ISGylation-independent protection of cell growth by USP18 following interferon stimulation
por: Clancy, Anne, et al.
Publicado: (2023)

Def defines a conserved nucleolar pathway that leads p53 to proteasome-independent degradation
por: Tao, Ting, et al.
Publicado: (2013)

Lipoic Acid Synergizes with Antineoplastic Drugs in Colorectal Cancer by Targeting p53 for Proteasomal Degradation
por: Neitzel, Carina, et al.
Publicado: (2019)

Ubiquitin receptors play redundant roles in the proteasomal degradation of the p53 repressor MDM2
por: Sparks, Alison, et al.
Publicado: (2022)

The transcription factor NRF1 (NFE2L1) activates aggrephagy by inducing p62 and GABARAPL1 after proteasome inhibition to maintain proteostasis
por: Hatanaka, Atsushi, et al.
Publicado: (2023)

Proteasomal Degradation of p53 by Human Papillomavirus E6 Oncoprotein Relies on the Structural Integrity of p53 Core Domain
por: Bernard, Xavier, et al.
Publicado: (2011)

Hax-1 is rapidly degraded by the proteasome dependent on its PEST sequence
por: Li, Bin, et al.
Publicado: (2012)

NQO1 potentiates apoptosis evasion and upregulates XIAP via inhibiting proteasome-mediated degradation SIRT6 in hepatocellular carcinoma
por: Zhou, Hong-Zhong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8u4odcpql0m37cel6pe73i105a